Back
Day Range
$25.78
$28.00
52-Week Range
$20.13
$41.22
Volume
2,008,872
50D / 200D Avg
$27.04
/
$30.49
Prev Close
$26.82
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -20.4 | 0.3 |
| P/B | 7.9 | 2.9 |
| ROE % | — | 3.7 |
| Net Margin % | -66.4 | 3.8 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$38.00
+35.9%
Forward EPS
-$0.56
Est. Revenue
220 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.64
$0.62 – $0.65
|
500 M | 1 |
| FY2029 |
$0.39
$0.38 – $0.39
|
420 M | 1 |
| FY2028 |
$0.03
-$0.03 – $0.10
|
330 M | 2 |
Key Takeaways
Debt/Equity of 0.07 — conservative balance sheet
Negative free cash flow of -59.05M
Capital efficient — spends only 2.85% of revenue on capex
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)39.92%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROIC-14.89%
Net Margin-66.35%
Op. Margin-36.39%
Safety
Debt / Equity
0.07
Current Ratio5.20
Interest Coverage-4.22
Valuation
P/E Ratio
-20.39
P/B Ratio7.92
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 39.92% | Revenue Growth (3Y) | 42.10% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 176.03M | Net Income (TTM) | -116.79M |
| ROE | N/A | ROA | -32.49% |
| Gross Margin | 76.80% | Operating Margin | -36.39% |
| Net Margin | -66.35% | Free Cash Flow (TTM) | -59.05M |
| ROIC | -14.89% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.07 | Current Ratio | 5.20 |
| Interest Coverage | -4.22 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -20.39 | P/B Ratio | 7.92 |
| P/S Ratio | 13.53 | PEG Ratio | 11.42 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 2.38B | Enterprise Value | 2.36B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | 176.03M | 125.81M | 87.17M |
| Net Income | -116.79M | -96.43M | -95.66M |
| EPS (Diluted) | -1.37 | -1.49 | -1.94 |
| Gross Profit | 135.20M | 94.45M | 58.05M |
| Operating Income | -64.07M | -61.22M | -72.91M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Total Assets | 359.45M | 118.70M | 185.05M |
| Total Liabilities | 58.81M | 978.19M | 962.62M |
| Shareholders' Equity | 300.65M | -859.48M | -777.56M |
| Total Debt | 22.05M | 160.38M | 160.60M |
| Cash & Equivalents | 44.78M | 51.37M | 122.77M |
| Current Assets | 220.20M | 82.29M | 148.45M |
| Current Liabilities | 42.37M | 33.61M | 32.82M |